The diagnosis and management of hemoglobinopathies during pregnancy.
Patients with hemoglobinopathies can be at risk for significant maternal and fetal morbidity during pregnancy. This is especially true for those gravidas with SCD or certain thalassemia disorders. With intensive management, pregnancy outcome for these women has improved dramatically, and approximates that of the general population. Criteria for diagnosis for many of these conditions are well established. Appropriate therapeutic interventions are more controversial, but, regardless, emphasize the need for a heightened awareness of these disorders and their potential complications.
Department of Obstetrics and Gynecology, University of Mississippi Medical Center, Jackson 39216-4505.
K G
KG
Perry
J C
JC
Morrison
D055598:Chemical Phenomena; D002621:Chemistry; D005260:Female; D006453:Hemoglobinopathies / Q000175:diagnosis* / Q000628:therapy*; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000175:diagnosis* / Q000628:therapy*
D006454:Hemoglobins